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Introduction: Different vascular beds show substantial variation in their susceptibilities for development of vascular
disease like atherosclerosis, and thereby exhibit a variety of different clinical presentations. Yet, the underlying mechanism
of this heterogeneity is not well defined. Recent evidence suggests a role for the vasa vasorum (VV) in vascular disease. We
hypothesized that there is a differential distribution structure of adventitial VV in different vascular beds. Hence, the
current study was designed to characterize and compare the structure of the adventitial VV in the coronary and the
peripheral circulation.
Methods: Samples of vessels from different vascular beds were obtained from 6 female crossbred domestic pigs. The
samples were scanned using micro–computed tomography, and the images reconstructed and analyzed to characterize VV
architecture, including vessel wall area, VV count, VV density, intravessel spatial distribution, mean diameter of first- and
second-order VVs and the ratio of second- to first-order VVs.
Results: There were significant differences in VV density among different vascular beds. Density was highest in coronary
arteries (2.91 0.26 vessels/mm2, P < .05, vs renal, carotid, and femoral arteries), intermediate in renal arteries (1.45
0.22 vessels/mm2, P < .05, vs femoral artery) and carotid arteries (0.64 0.08 vessels/mm2, P < .05, vs femoral artery),
and lowest in femoral arteries (0.23 0.05 vessels/mm2). A similar pattern for the ratio of second- to first-order VV was
also observed. Random intravessel spatial distribution of VVs was seen in all vascular beds.
Conclusion: The current study demonstrates a differential structure of the adventitial VV in different vascular beds. This
intra- and intervessel heterogeneity in VV anatomy is a phenotypic variability that might determine a differential local
response to systemic risk factors and, thereby, variable propensity for vascular disease among different vascular beds.
( J Vasc Surg 2004;40:529-35.)
Clinical Relevance: Atherosclerosis is a diffuse disease with differential expression among different vascular beds,
inflicting a spectrum of vascular diseases. The majority of research efforts focus on the inner and medial vascular layers,
which are in fact affected at the late stage of atherosclerosis. However, recent evidence suggests that the outer wall,
including the adventitial layer and the vasa vasorum, plays a significant role in maintaining vessel integrity, contributing
to the initiation and progression of atherosclerosis. The current article extends these previous observations. Using a novel
imaging technology, micro–computed tomography, we demonstrate structural heterogeneity of the adventitial vasa
vasorum among different vascular beds. This heterogeneity in VV anatomy is a phenotypic variability that might
determine a differential local response to systematic risk factors and a concomitant variable propensity for vascular disease
among different vascular beds. Furthermore, it suggests that anti-angiogenic treatment aimed at attenuating the VV
neovascularization may have a potential preventive or reversal measure against the progression of atherosclerosis.Although considered a single system, different
branches of the vascular tree show substantial variation in
their susceptibility for development of vascular diseases
such as atherosclerosis. Potential heterogeneity in the spa-
tial density of the adventitial vasa vasorum among different
vascular beds may be a mechanism underlying the subse-
quent differential expression of disease observed in differ-
ent arterial branches.
Pathologies in the vascular tree exhibit a variety of
different clinical presentations depending on the location of
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doi:10.1016/j.jvs.2004.06.032the disease process, the most severe consequences being
myocardial infarction, gangrene, stroke, and ischemic ne-
phropathy.1 Furthermore, data recently published by the
American Heart Association reflect that atherosclerosis af-
fects different vascular beds to a different extent,1—a sig-
nificant difference exists in the prevalence and severity of
the atherosclerotic lesions in coronary, cerebrovascular,
and peripheral circulation. These clinical findings are sup-
ported by autopsy-based studies demonstrating heteroge-
neity in vascular disease process, severity, and incidence
among different arterial beds.2-5 This heterogeneous distri-
bution pattern is remarkable given the systemic exposure to
cardiovascular risk factors such as hypercholesterolemia and
hypertension, and attributes an important pathophysio-
logic role to local factors, including the vascular wall struc-
ture. However, the underlying mechanism of this hetero-
geneous response is not yet defined.
Previously, a passive role in the pathophysiology of
vascular disease has been ascribed to the outer wall, which
includes the adventitial layer and the vasa vasorum (VV). In
contrast to this traditional view, recent evidence suggests529
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maintaining vessel integrity, and may contribute to the
initiation and progression of arthritis and atherosclerosis.6,7
Indeed, experimental studies demonstrated that manipula-
tion of the adventitia and more specifically of the VV
(removal of the adventitia or obstruction or hypoperfusion
of the VV) could lead to the atherosclerotic changes of the
intima.8-12 Studies have also demonstrated that lesion for-
mation is associated with proliferation of VVs at the site of
the lesion formation.13-15 Attenuation and regression of
the atherosclerotic process with medical intervention
(HMG-CoA) has been associated with a decrease in VV
density.16 These studies underscore the role of the adven-
titial VV in the pathophysiology of vascular diseases. How-
Fig 1. Representative micro–computed tomography im
ratio among the different vascular beds (B).ever, these studies were performed on the coronary vascu-
lature and none of them addressed the heterogeneous
distribution pattern among different vascular beds as it
relates to adventitial and VV structure. As stated earlier,
potential heterogeneity in the spatial density of the adven-
titial VV among different vascular beds may be one of the
mechanisms underlying the subsequent differential expres-
sion of disease observed in these beds.
The current study was designed to test the hypothesis
that there is a differential structure of adventitial VV in
different vascular beds. Specifically, the spatial density, dis-
tribution, diameter of first- and second-order VVs, and the
ratio of second- and first-order VVs in the coronary, renal,
carotid, and femoral circulation were examined.
(A) and vasa vasorum density with second- to first-orderages
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Animals. This study was reviewed and approved by
the Mayo Clinic Institutional Animal Care and Use Com-
mittee. Experiments were conducted on 6 normal female
crossbred domestic pigs of similar ages (50-70 kg, 5-6
months old) (Larson Products, Sargeant, Minn). The swine
is an appealing model for studying human disease because
its cardiovascular anatomy and physiology are comparable
to humans’, and lipid profile and development of vascular
disease in pigs closely resembles human disease.17 The
animals were euthanized with an overdose of sodium pen-
tobarbital (10 mL Sleepaway; Fort Dodge Laboratories,
Fort Dodge, Iowa) and the coronary (left anterior descend-
ing [LAD]-medial segments), carotid, renal, and femoral
arteries (both sides, medial segments) were harvested im-
mediately after euthanasia. Due to its low incidence of
atherosclerosis,18,19 the left internal mammary artery
(LIMA) was examined as well.
Micro–computed tomography analysis. Segments
of the arteries were prepared and scanned by micro–com-
puted tomography (micro-CT) as described previous-
ly.20-22 Briefly, a glass cannula was advanced into the most
proximal part of each artery, followed by injection of 500
mL heparinized saline (0.9% sodium chloride with 5,000
IU of heparin) at an infusion rate of 10 mL/min to clear the
circulation from remaining blood and microthrombi. Next
a low-viscosity (20-centipoise) lead chromate–doped sili-
con polymer (MicrofilTM, MV-122; Canton Biomedical
Products, Boulder, Colo) was injected into the regional
circulation at a rate of 0.6 mL/min (pressure 70 mm Hg)
until the polymer emerged from the veins. After overnight
refrigeration at 4°C to allow polymerization of the com-
pound, the arteries were carefully dissected, with the adven-
titia preserved intact, and placed in a 36.5% formaldehyde
solution. Subsequently, specimens were placed in glycerin
solution at increasing concentrations (30%, 50%, 75%, and
100% changed at 24-hour intervals) for dehydration of the
segments and were thereafter rinsed with acetone, air-dried
for 24 hours, and embedded in a paraffin mold for 3-di-
mensional (3D) Micro-CT imaging.
This yielded an image with a 3D matrix of 42-m cubic
voxels with 16 bits of gray scale (Fig 1). Data analysis was
Micro–computed tomography analysis data
Coronary artery
Vessel wall area (mm2 mean/section) 2.1  0.1*†‡§
VV count (n mean/section) 6.5 0.6‡§
VV density (n/mm2 mean/section) 2.9  0.3*†‡§
Ratio 2nd/1st order VV (mean/section) 4.2 0.5*†‡§
Diameter 1st order VV (m) 84.2  2.4* 1
Diameter 2nd order VV (m) 58.1  2.2*‡
VV, Vasa vasorum.
*P  0.05 vs renal artery.
†P  0.05 vs carotid artery.
‡P  0.05 vs femoral artery.
§P  0.05 vs left internal mammary artery.performed using Analyze software (Biomedical Imaging
Resource, Rochester, Minn). On average, 6 to 12 cross
sections at 1-mm intervals, in areas between branch points,
were chosen as regions of interest for analysis. The area of
VV analysis was determined as previously described by
Edelman et al,23—in short, the radius of the vessel, includ-
ing the lumen and the wall, is doubled to determine the VV
area borders. In this way the VV area is normalized to the
vessel lumen area and designated vessel wall area.16,22,24
VVs were manually traced and measured in this area on
each cross section, yielding the following parameters: vessel
wall area, VV count, density (ie, number VV/mm2 vessel
wall area), intravessel spatial distribution, and mean diam-
eter and ratio of second- and first-order VVs. First-order
VVs are defined as those originating from the vessel lumen
and running longitudinally, and second-order VVs as those
originating from first-order VVs and running circumferen-
tially.25
Statistical analysis. Continuous data are expressed as
mean  standard error. Multiple group comparison was
based on Kruskal-Wallis one-way analysis of variance on
ranks and Spearman Rank Order Correlation. Statistical
significance was accepted for a value of P  .05.
RESULTS
Histology cross sections from all sites showed that the
vessels were free of atherosclerotic lesions.
Vessel wall area, VV count, and VV density. Vessel
wall area was highest for the femoral artery, decreasing
significantly in the renal and coronary arteries (left anterior
descending–medial segment). The VV count was signifi-
cantly low in the femoral artery versus the other vascular
beds (Table). Consequently, as displayed in Fig 1, VV
density was highest in the coronary arteries, intermediate
for renal and carotid arteries, and lowest in the femoral
arteries.
Ratio of second- to first-order VVs. The ratio of
second- to first-order VVs was highest in the coronary
arteries, followed by the renal, carotid and femoral arteries,
respectively (Fig 1). A significant positive correlation was
found between VV density and the ratio of second- to
l artery Carotid artery Femoral artery
Left internal
mammary artery
 0.7‡ 12.3  1.6§ 12.6  1.2§ 7.2  0.3
 1‡§ 5.7  0.9‡§ 1.9  0.3 1.6  0.3
 0.2‡§ 0.6  0.1‡§ 0.2  0.05 0.2  0.04
 0.5§ 1.5  0.3 1.1 0.2 0.8  0.2
 5.4†‡§ 84.5  5.1 94.9 7.4 71.2  10
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artery (Fig 2).
Vasa vasorum diameter. First-order VV diameter was
highest in the renal artery, with a significant difference
between it and the other vascular beds that were similar to
each other. Second-order VV diameter was lowest in the
coronary artery, with a significant increase in size in the
carotid, renal, and femoral arteries (Table).
Intravessel spatial distribution of VV. Analyzing
the spatial distribution of the VVs within each vessel26
showed intravessel heterogeneity, but no evident pattern
was detected in any of the vascular beds.
Left internal mammary artery. The LIMA was ex-
amined due to its low incidence of atherosclerosis. As
displayed in the Table, VV area, count, and density differed
significantly between the LIMA and the coronary, renal,
and carotid arteries. Compared with the LIMA, the sec-
ond- to first-order VV ratio was significantly higher in the
coronary and renal arteries and second-order VV diameter
was significantly higher in all vessels.
DISCUSSION
The current study demonstrates heterogeneity in the
distribution of VVs among different vascular beds. Nota-
bly, the variability in this anatomic feature can support the
theory of phenotypic differences among different vascular
beds and may relate to the differential expression patterns
of atherosclerotic cardiovascular disease (ASCVD). The
tendency of atherosclerosis to localize in arterial bifurcation
led to the recognition that hemodynamic features, such as
low shear stress forces, turbulence, and oscillatory flows,
which are present in bifurcation areas, play a major role in
the localization of the atherosclerotic plaque. Nevertheless,
different vascular sites are sensitive to various extents with
Fig 2. Correlation between second- to first-order ratio a
shows all the vessels compiled. When tested separately al
carotid artery.regard to systemic factors such as hypercholesterol-
emia,27,28 genetic background,29 increased oxidative
stress,30 gender,31 and immune status,29 resulting in the
heterogeneous distribution of disease. VanderLaan et al32
suggested differential gene expression profiles of the vascu-
lar cells in different vascular beds in response to the local
flow patterns. Although speculative, such differences in the
gene expression can determine a different local response to
systemic risk factors resulting in differences in size, compo-
sition and progression of the atherosclerotic lesion. In
addition, anatomic heterogeneity can contribute to varia-
tions in vascular vulnerability.
Previous studies demonstrated proliferation of adven-
titial VV in the atherosclerotic vessels.8-12 Micro-CT is a
novel technology, which by tomographic reconstruction of
the adventitia enabled us to outline and quantify the 3D
anatomy of VV.20-22 We have previously demonstrated that
early atherosclerosis is characterized by neovascularization
of the porcine coronary arteries, suggesting a significant
role of the adventitial vasa vasorum prior to vasofunctional
alterations and plaque formation.16,24
In the current study we applied the micro-CT technol-
ogy to the porcine peripheral circulation, showing hetero-
geneity of VV density among different vascular beds. The
VV is regarded as the vascular bed of the vessel wall. Hence,
this observation of anatomical variability might be the
result of vessel wall exposure to different oxygen ten-
sion.33,34 Increase in wall thickness causes a decrease in the
oxygen content of the blood within the vessel wall as the
diffusion distance from the lumen increases. Hence, a dif-
ference in wall thickness between different vascular beds
necessitates different extents of VV network in order to
deliver nutrients and oxygen to the vascular wall. The
finding of a positive direct correlation between VV spatial
sa vasorum density in different vascular beds. The figure
ascular bed showed a positive correlation except for thend va
l the v
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that this intervessel variability is achieved by variation in the
second order of the VVs. In a previous work we observed a
similar correlation in vessels exposed to hypercholesterol-
emia, indicating that proliferation of second order VVs is
related to the early atherosclerotic process.35 On the other
hand, in addition to VV density, the regulation of the
perfusion of the vessel wall is dependent also on the endo-
thelium, which is a highly vulnerable target organ in AS-
CVD. Exposure to risk factors causes endothelial dysfunc-
tion at an early stage. Since VV has the complete structure
of a blood vessel, endothelial dysfunction is present at its
level as well as at the level of the host vessel.36-40 Under
baseline conditions (eg, the absence of risk factor) like
those in the current study, the host vessel is in a steady state,
receiving ample nutrient and oxygen supply. However, as
demonstrated in our previous studies,16,24,35,41 once this
equilibrium is disturbed and vessel wall hypoxia occurs,
vessel growth, eg, VV neovascularization, is triggered by
signaling through hypoxia inducible transcription factors
and downstream angiogenic factors such as vascular endo-
thelial growth factor.
Having a significantly (more than 70 times) higher
endothelial surface area, the presence of endothelial dys-
function at the VV level might have more of an impact on
vascular wall perfusion than the host vessel and might
render it more susceptible to atherogenesis. This is sup-
ported by a study in ApoE-deficient mice, showing that
anti-angiogenic therapy not only reduced plaque neovascu-
larization but eventually plaque growth.42 Thus, when
vascular beds are exposed to risk factors, one may anticipate
variability in vasoreactivity between different vascular beds
due to the difference in VV spatial density; eg, vessels with
low VV density at their steady state will be less affected.
Furthermore, the extensive VV network can function as a
conduit for entry of macrophages and inflammatory factors
that may potentially promote the progression of angiogen-
esis and plaque formation. Indeed, inhibition of angiogen-
esis has been shown to reduce macrophages in the plaque
and around the VV.43 The relationship between the adven-
titial VV and the development of atherosclerosis is further
supported by our observation that the LIMA, a vessel with
low incidence of atherosclerosis,16,17 shows a significantly
lower VV density.
Furthermore, the contribution of VVs to vascular dis-
ease may also be mediated by their physical fragility, al-
though the notion of VV fragility is not tested in the
current study. Intraplaque hemorrhage is common in ad-
vanced atherosclerotic lesions and its occurrence is consid-
ered an important event in the manifestation of atheroscle-
rotic disease, causing acute processes such as myocardial
infarction as well as cerebrovascular and peripheral acute
ischemia.44-46 Previous studies have demonstrated the as-
sociation between plaque neovascularity and quantity of
intraplaque hemorrhage.47-49 In the current study, the
variability in VV density was accounted for by the second-
order VVs. These microvessels are smaller in diameter than
the first-order VVs, less mature, and might be more suscep-tible to hemorrhage, especially in the presence of hyperten-
sion. Thus, this observation can support the association
between neovascularization and intraplaque hemorrhage.
Gössl et al26 recently showed patchy distribution of VV
territories in the vessel wall of the LAD artery. Using the
same methodology, our findings show similar random dis-
tribution of VVs within the vessel walls of the carotid, renal
and femoral as well as the coronary arteries. This absence of
a detectable pattern in different vascular beds is in accord
with the non-uniform distribution of the atherosclerotic
plaque on the intimal surface of the vessels3,4 and further
supports the possible pathophysiologic role of VV density
in plaque formation.
Study limitations. The current study describes the
structural micro-anatomy of the normal vessel wall in 5
different vascular beds. Although the increase in VV density
in the atherosclerotic process is well documented, it is
possible that the VVs observed in the normal vessels are not
related to the newly formed VVs observed in vessels under
atherogenic stimuli. Furthermore, the current study is de-
scriptive and involves neither molecular pathophysiologic
mechanism of the vascular disease nor physical properties of
the VV (eg, VV fragility). Nevertheless, the significant
anatomic differences between the different vascular beds
are in line with the growing evidence in the literature
supporting the role of VV in vascular disease.
In conclusion, different vascular beds exhibit intra- and
intervessel heterogeneity in VV anatomy, a phenotypic
variability that might determine their differential local re-
sponse to systemic risk factors and propensity for develop-
ment of atherosclerosis. The coronary vasculature, which is
most affected by the atherosclerotic process1,2,4 was found
to have the highest VV density, thereby supporting a pos-
sible pathophysiologic role of VV in atherosclerosis. In-
flammatory arterial diseases such as Takayasu’s disease,
Bechet disease, and temporal arteritis show progression of
the inflammatory process from the adventitia, (eg, vasa
vasoritis) toward the inner layers of the vessel wall (vascu-
litis).50 Whether higher VV density exposes the host vessel
to an increase inflammatory process is unknown; however,
the inflammatory process is well recognized in the athero-
sclerosis pathophysiology. Hence, further investigation ex-
ploring the variability in vasoreactivity and expression of
growth factors and inflammatory markers, with and with-
out exposure to risk factors, is warranted in order to eluci-
date the underlying mechanism and potential of ASCVD
heterogeneity.
Dr Amir Lerman is an Established Investigator of the
American Heart Association.
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